SpliceBio has dosed the first patient in the Part B dose-expansion portion of its phase 1/2 ASTRA clinical trial ( ...
Pancreatic cancer is notoriously hard to treat, often resisting therapies that target its most common mutations. Researchers ...
News Medical on MSN
Why Some Retinitis Pigmentosa Cases Went Undiagnosed for Decades
Researchers led by the Institute of Molecular and Clinical Ophthalmology Basel uncovered disease-causing variants in ...
News-Medical.Net on MSN
RNA gene mutations identified as cause of inherited blindness
Researchers from Radboud university medical center and University of Basel have discovered new genetic causes of inherited ...
US biotech ecosystem company Alloy Therapeutics has appointed Christian Cobaugh as chief executive of its Genetic Medicines ...
Pancreatic ductal adenocarcinoma (PDAC) is both the most common and the deadliest type of pancreatic cancer. Most treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback